rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Paul A. Bunn

Director

Company insider

Files Form 4 as: Director, Verastem.

In numbers

Trades disclosed
16
Buys
0
Sells
2
Bought
$0
Sold
$138K
Companies
1
Companies where not an officer
1
First trade
24 Jun 2021
Last trade
21 May 2026
Last filed
26 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
VSTM VerastemDirector · Biotechnology · last 21 May 20260 buys · 2 sells

Activity over time

1 Oct 2025 – 1 Oct 2026
10Oct 25Jan 26Apr 26Jul 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
21 May 2026filed 26 May 2026VSTM VerastemBiotechnologySEC FORM 4 Code A—36,000 at $0.00filing
21 May 2026filed 26 May 2026VSTM VerastemBiotechnologySEC FORM 4 Code A—36,000 at $0.00filing
21 Nov 2025filed 25 Nov 2025VSTM Verastemoption or derivative · BiotechnologySEC FORM 4 Code M—6,250 at $0.00filing
21 Nov 2025filed 25 Nov 2025VSTM VerastemBiotechnologySEC FORM 4 Sold$63K6,250 at $10.00filing
21 Nov 2025filed 25 Nov 2025VSTM VerastemBiotechnologySEC FORM 4 Code M$20K6,250 at $3.27filing
9 Oct 2025filed 14 Oct 2025VSTM VerastemBiotechnologySEC FORM 4 Sold$75K8,333 at $9.06filing
22 May 2025filed 27 May 2025VSTM Verastemoption or derivative · BiotechnologySEC FORM 4 Code A—12,500 at $0.00filing
22 May 2025filed 27 May 2025VSTM VerastemBiotechnologySEC FORM 4 Code A—8,333 at $0.00filing
18 Jun 2024filed 20 Jun 2024VSTM Verastemoption or derivative · BiotechnologySEC FORM 4 Code A—12,500 at $0.00filing
18 Jun 2024filed 20 Jun 2024VSTM VerastemBiotechnologySEC FORM 4 Code A—8,333 at $0.00filing
11 Mar 2024filed 13 Mar 2024VSTM Verastemoption or derivative · BiotechnologySEC FORM 4 Code D—6,113filing
11 Mar 2024filed 13 Mar 2024VSTM Verastemoption or derivative · BiotechnologySEC FORM 4 Code A—6,113filing
15 May 2023filed 16 May 2023VSTM Verastemoption or derivative · BiotechnologySEC FORM 4 Code A—62,500 at $0.00filing
22 Jun 2022filed 24 Jun 2022VSTM Verastemoption or derivative · BiotechnologySEC FORM 4 Code A—62,500 at $0.00filing
12 May 2022filed 20 Dec 2022VSTM Verastemoption or derivative · BiotechnologySEC FORM 4 Code A—62,500 at $0.00filing
24 Jun 2021filed 28 Jun 2021VSTM Verastemoption or derivative · BiotechnologySEC FORM 4 Code A—73,356 at $0.00filing

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Dan PatersonPresident and CEO · President and CEO at Verastem, filing Form 4 there in the last year
Daniel CalkinsChief Financial Officer · Chief Financial Officer at Verastem, filing Form 4 there in the last year
Michael P. BaileyDirector · Director at Verastem, filing Form 4 there in the last year
Karin Anna TollefsonDirector · Director at Verastem, filing Form 4 there in the last year
Eric K. RowinskyDirector · Director at Verastem, filing Form 4 there in the last year